27 October 2011 CHE Partnership Call: New Frontiers in Cancer Research: How Chemicals Can Interfere with Cancer Therapies and Implications for Health Policy

Widely noted research published recently indicated that the presence of chemicals like BPA and methylparaben can interfere with commonly-used breast cancer therapies. This call featured the lead author of that study, William Goodson, MD, as well as Mhel Kavanaugh-Lynch, MD, MPH, who discussed health policy opportunities based on this research and other studies associating chemical exposures with breast cancer. Ted Schettler, MD, MPH also provided a brief update on new science relevant to this topic.